Another review on the takeover.--http://ibtimes.com.au/articles/20100401/12billion-in-bids-macarthur-says-no-lihir-says-no.htm
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%